Clinical characteristics of survivors
| CHARACTERISTICS | SURVIVORS (N = 1157*), N (%) |
|---|---|
| Age at diagnosis, y | |
| • 0–4 | 404 (35.0) |
| • 5–9 | 217 (18.8) |
| • 10–14 | 218 (18.9) |
| • 15–19 | 315 (27.3) |
| Time since diagnosis, y | |
| • 5–9 | 194 (16.9) |
| • 10–14 | 377 (32.9) |
| • 15–19 | 283 (24.7) |
| • 20–24 | 188 (16.4) |
| • ≥ 25 | 103 (9.0) |
| Diagnosis | |
| • ALL | 242 (20.9) |
| • Other leukemia | 30 (2.6) |
| • Hodgkins lymphoma | 135 (11.7) |
| • Non-Hodgkins lymphoma | 65 (5.6) |
| • CNS tumour | 229 (19.8) |
| • Renal tumour | 73 (6.3) |
| • Bone tumour | 52 (4.5) |
| • Carcinomas | 102 (8.8) |
| • Other | 229 (19.8) |
| Period of diagnosis | |
| • 1970–1980 (11 y) | 259 (22.4) |
| • 1981–1990 (10 y) | 618 (53.4) |
| • 1991–1995 (6 y) | 280 (24.2) |
| Treatment | |
| • Surgery only | 243 (21.0) |
| • Radiation only | 46 (4.0) |
| • Chemotherapy only | 194 (16.8) |
| • Chemotherapy and surgery | 150 (13.0) |
| • Chemotherapy and radiation | 208 (18.0) |
| • Radiation and surgery | 138 (11.9) |
| • Chemotherapy, radiation, and surgery | 105 (9.1) |
| • Unknown | 73 (6.3) |
ALL—acute lymphoblastic leukemia, CNS—central nervous system.
↵* Data were not available for all survivors for all characteristics.